Search for: "TM, LLC" Results 161 - 180 of 366
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
19 Jul 2017, 11:46 am by Phyllis H. Marcus
Tyson’s Hot Dog TM Suit is Going, Going Gone Tyson Foods and Hillshire Brands received a thumbs-up from the Third Circuit to continue using “Park’s Finest” for its Ball Park brand hot dogs. [read post]
Tyson’s Hot Dog TM Suit is Going, Going Gone Tyson Foods and Hillshire Brands received a thumbs-up from the Third Circuit to continue using “Park’s Finest” for its Ball Park brand hot dogs. [read post]
30 May 2017, 8:00 am by Rebecca Tushnet
Hillair Capital Management, LLC, --- Fed.Appx. ----, 2017 WL 2304376, No. 16-56217 (9th Cir. [read post]
8 Feb 2017, 3:09 am by Dennis Crouch
Fossil, Inc., et al, No. 16-202 (SCA Redux plus TM issue) Eligibility: TDE Petroleum Data Solutions, Inc. v. [read post]
16 Jan 2017, 5:44 pm by Dennis Crouch
Fossil, Inc., et al, No. 16-202 (SCA Redux plus TM issue) Eligibility and CBM: DataTreasury Corporation v. [read post]
8 Dec 2016, 3:30 am
In re 2nd Life Tech, LLC, Serial No. 86415828 (December 2, 2016) [not precedential].Applicant's specimen of use consisted of a Kickstarter page displaying the mark in the upper left hand corner beneath the KICKSTARTER mark. [read post]
14 Nov 2016, 9:16 am by Dennis Crouch
Fossil, Inc., et al, No. 16-202 (SCA Redux plus TM issue) Post Grant Admin: Ethicon Endo-Surgery, Inc. v. [read post]
13 Oct 2016, 6:50 am by Dennis Crouch
Fossil, Inc., et al, No. 16-202 (SCA Redux plus TM issue) Post Grant Admin: Ethicon Endo-Surgery, Inc. v. [read post]
28 Sep 2016, 8:39 am by Dennis Crouch
Fossil, Inc., et al, No. 16-202 (SCA Redux plus TM issue) Safe Harbor: Amphastar Pharmaceuticals, Inc., et al. v. [read post]
18 Sep 2016, 6:03 pm by Dennis Crouch
Fossil, Inc., et al, No. 16-202 (SCA Redux plus TM issue) Safe Harbor: Amphastar Pharmaceuticals, Inc., et al. v. [read post]
5 Sep 2016, 6:46 pm by Dennis Crouch
Fossil, Inc., et al, No. 16-202 (SCA Redux plus TM issue) Safe Harbor: Amphastar Pharmaceuticals, Inc., et al. v. [read post]
30 Jun 2016, 10:44 am by Rebecca Tushnet
In 2014, Professor De Simone decided to leave VSL Pharmaceuticals and is now collaborating with ExeGi Pharma, LLC to produce Visbiome, a probiotic using the same proprietary blend of probiotic strains that De Simone originally invented.ExeGi launched Visbiome on February 1, 2016, the day after the agreement between VSL and Danisco, the original manufacturer of VSL#3 and current manufacturer of Visbiome, expired on January 31, 2016. [read post]